Activity Details

Accredited By

American Heart Association

Target Audience

Physicians and Nurses specific to treating patients with heart failure

Learning Objectives

At the completion of this course, the learner will be able to:

• List different approaches to treatment of heart failure with reduced fraction (HFrEF) and heart failure with preserved ejection fraction (HFpEF).
• Describe the different approaches to diagnosis and classification of heart failure.
• List effective ways to ensure appropriate transition of care from the inpatient to outpatient setting.
• Identify different diagnostic techniques and the various diagnosis options for heart failure patients and the importance of the correct diagnosis for follow-up treatment.
• Apply strategies to improve the implementation of evidence-based heart failure guidelines and improved coordination of care amongst patient teams.
• Discuss the updated guidelines surrounding newly FDA approved device options and their implications for the heart failure patient.

Activity Description

As an extension of the content covered in the first webinar, the second will address challenges, areas identified as greatest need from the first webinar and to reinforce practice and behavior aspects that will contribute to improved patient care and outcomes.

Statement of Educational Need

With the release of new guidelines, healthcare professionals will need education and learning in order to change practice and behavior for the care and treatment of patients with or at risk of cardiovascular disease. This multifaceted education initiative is an important opportunity to educate healthcare professionals on evidence-based guidelines, especially newly released, addressing changes, evidence, and action that can be put into practice immediately to impact patient care and outcomes.

Agenda

5 minutes – Introduction
10 minutes – Medication categories and Rationale for use
10 minutes – Transition care
10 minutes – Challenges in Self-Management of Heart Failure
10 minutes – Human connection
10 minutes – Case Studies
5 minutes – Q & A
5 minutes – Closing remarks

Presenters: Mark Drazner, MD, Robin Trupp, PhD, ACNP-BC, APRN, CHFN, FAHA, & Nancy Albert, PhD, CCNS, CHFN, CCRN, FAHA

Planning Committee

Mark Drazner, MD – Planning Committee Chair, course author
Clinical Chief of Cardiology
Medical Director of the LVAD and Cardiac Transplantation Program
Professor of Internal Medicine
UT Southwestern

Deborah Crabbe, MD – Planning Committee, course author
Professor of Medicine
Lewis Katz School of Medicine
Temple University

Robin Trupp, PhD, ACNP-BC, APRN, CHFN, FAHA – Planning Committee, course author
Adjunct Assistant Clinical Professor
University of Illinois at Chicago School of Medicine

Nancy Albert, PhD, CCNS, CHFN, CCRN, FAHA – Planning Committee, course author
Associate Chief Nursing Officer
Research and Innovation
Cleveland Clinic Health System, Kaufman Center for Heart Failure

Disclosures

All persons who develop and/or control educational content in CME/CE activities provided by the American Heart Association will disclose to the audience all financial relationships with any commercial supporters of this activity as well as with other commercial interests whose lines of business are related to the CME/CE-certified content of this activity. In addition, presenters will disclose unlabeled/unapproved uses of drugs or devices discussed in their presentations. Such disclosures will be made in writing in course presentation materials.

The disclosures listed below represents the relationships of this educational activity’s faculty members that may be perceived as actual or reasonable perceived conflicts of interest as reported on the Disclosure Questionnaire which all AHA volunteers are required to complete and submit. The focus is on relevant financial relationships with commercial interests in the 12-month period preceding the time that the individual is being asked to assume a role controlling content.

Mark Drazner, MD – No Disclosures
Deborah Crabbe, MD – No Disclosures
Robin Trupp, PhD, ACNP-BC, APRN, CHFN, FAHA – Employed by Roche Diagnostics Corp.
Nancy Albert, PhD, CCNS, CHFN, CCRN, FAHA – Novartis: Speaker bureau, consultant on research projects; Amgen: Speaker bureau

Accreditation Statements

ORIGINAL RELEASE DATE: 05/05/2017

TERMINATION DATE: 05/02/2020

LAST REVIEW DATE: April 2017

JOINT ACCREDITATION TERM: 05/02/2017 - 05/02/2020

The American Heart Association is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME), to provide continuing education for the healthcare team.

AMA Credit Designation Statement – Physicians
The American Heart Association designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AAPA Credit Acceptance Statement – Physician Assistants
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 1.0 hour of Category 1 credit for completing this program.

AANP Credit Acceptance Statement – Nurse Practitioners
American Academy of Nurse Practitioners (AANP) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. **AMA Credit must be claimed within 6 months of attendance. Credit will no longer be available to claim after the 6 months claiming period.

ANCC Credit Designation Statement – Nurses
The maximum number of hours awarded for this CE activity is 1.0 contact hour. **ANCC Credit must be claimed within 6 months of attendance. CME/CE will no longer be available to claim after the 6 months claiming period.

Participation and Successful Completion

Successful completion of this CME/CE activity includes the following:

• Register and view the course online.
• View the content in its entirety.
• Complete a post-test with a minimum score of 80%.
• Complete a survey of your learning experience.
• Claim your CME/CE Certificate.

Statement of Commercial Support

This activity is supported by independent medical educational grants from Novartis.

Disclaimer Statement

When an unlabeled use of a commercial product or an investigational use not yet approved for any purpose is discussed during an educational activity, the faculty must disclose that the product is not labeled for the use under discussion or that the product is still investigational.

Contact Information for Questions About the Activity

Fred Porta
Manager, Lifelong Learning
AHA National Center
fred.porta@heart.org
817-412-1941

Hardware/Software Requirements

Pro-CME recommends using the latest versions of these supported browsers: Google Chrome, Microsoft Internet Explorer, Mozilla Firefox, Safari. Depending on your browser of choice, additional software, such as Adobe Reader® and Adobe® Flash® Player may be required.